| Generic medicine pricing in Europe: current issues and future perspective. | |
| | |
MedLine Citation:
|
PMID: 19450118 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
This editorial discusses a number of trends affecting the pricing of generic medicines in Europe. With respect to pricing, recent evidence has emerged that European generic medicine manufacturers face competition from Indian manufacturers; that the price level of generic medicines varies substantially between European countries; and that generic medicine manufacturers engage in competition by discount rather than price competition in France, The Netherlands and the UK. These trends suggest that there may be scope for further reducing the prices of generic medicines in several countries. In relation to reference pricing, most European countries have incorporated market incentives within reference pricing systems with a view to promoting price competition. The European experience indicates that the generic medicines industry delivers competitive prices under a reference pricing system if demand-side policies are in place that stimulate physicians, pharmacists and patients to use generic medicines. Finally, caution needs to be exercised when focusing on the drivers of generic medicine pricing as these drivers not only vary between countries, but may also vary within a country. Manufacturers of originator and generic medicines do not take a single pricing approach following patent expiry, but vary their pricing strategy from molecule to molecule. |
| | |
Authors:
|
Steven Simoens |
Related Documents
:
|
2488588 - Synthesis of buffers for generating immobilized ph gradients. ii: basic acrylamido buff... 22398068 - Monitoring inflammatory bowel disease activity: clinical activity is judged to be more ... 17877848 - International comparison of generic medicine prices. 21469478 - Assessment and management of paediatric burn injuries. 20929518 - Highlights from the history of sexual medicine. 15768328 - Managing infections in the immunocompromised patient. |
Publication Detail:
|
Type: Editorial |
Journal Detail:
|
Title: Journal of medical economics Volume: 11 ISSN: 1369-6998 ISO Abbreviation: J Med Econ Publication Date: 2008 |
Date Detail:
|
Created Date: 2009-05-19 Completed Date: 2009-06-05 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9892255 Medline TA: J Med Econ Country: England |
Other Details:
|
Languages: eng Pagination: 171-5 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Drug Costs Drug Industry / economics* Drugs, Generic* Europe Humans Internationality |
| Chemical | |
Reg. No./Substance:
|
0/Drugs, Generic |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Cost minimisation analysis of 12 or 24 weeks of peginterferon alfa-2b + ribavirin for hepatitis C vi...
Next Document: A critical review of the full economic evaluations of pharmacological treatments for colorectal canc...